₹ 2,671.10
76.20 (2.94%)
G
Glenmark Pharmaceuticals
₹ 2,671.10
GLENMARK Financials Summary (Consolidated)
Glenmark Pharmaceuticals revenue increased 4.06% quarter-on-quarter to ₹4,160 Cr in Sep 2026, while net profit decreased 45.36% quarter-on-quarter to ₹264 Cr. Compared to the same quarter last year, revenue is down 32.96% and net profit is down 56.78%. EPS for the quarter stood at ₹9.35, decreased from ₹17.11 in the previous quarter and down from ₹21.63 a year ago.
Glenmark Pharmaceuticals Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of GLENMARK Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
GLENMARK Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






